COMPANY

Ancilia Biosciences

HQ: Long Island City, NY source · anciliabio.com ↗ · Mid-Atlantic

Keywords: CRISPR

Location: Long Island City, NY · source · Oct 14, 2026

Profile checked Oct 10, 2026

Funding and NIH signals

SEC Form D raise Raised $10.08M (Form D filed Apr 6, 2026). SEC Form D 0001975776-26-000006 (Apr 6, 2026)
Evidence (1 event)
- Apr 6, 2026 · SEC Form D 0001975776-26-000006
  Name of Issuer: Ancilia Biosciences, Inc.; CIK: 1975776; Address: New York, NY; Submission type: D; Filing date: 2026-04-06; Industry Group: Other; Date of First Sale: 2026-02-13; Types of Securities Offered: Equity; Business combination transaction: false; Total Offering Amount: 10076464; Total Amount Sold: 10076464; Federal exemptions: 06b

Job counts as of Oct 18, 2026. All funding and NIH signals

Oct 23, 2024 Grant Government grant: $3M (total, as published), announced Oct 23, 2024. Source: company's own press page. source ↗

Last 2 years.

Oct 23, 2024 Government grant: $3M (total, as published), announced Oct 23, 2024. Source: company's own press page. source ↗